GE Healthcare Technologies Inc. income statement & cash flow
In the fiscal year ended Dec 31, 2025, GE Healthcare Technologies Inc. reported net income of $2.08B on revenue of $20.62B. Operating cash flow was $1.99B.
Income statement and cash flow summary
| Fiscal year ended | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | $17.59B | $18.34B | $19.55B | $19.67B | $20.62B |
| Gross profit | $7.17B | $7.18B | $7.92B | $8.21B | $8.25B |
| Operating income | $2.79B | $2.52B | $2.44B | $2.62B | $2.76B |
| Net income | $2.25B | $1.92B | $1.57B | $1.99B | $2.08B |
| Diluted EPS | $4.95 | $4.22 | $3.03 | $4.34 | $4.55 |
| Operating cash flow | $1.61B | $2.13B | $2.10B | $1.96B | $1.99B |
| Reported in | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 | 10-K 2026 |
Margins
Each figure divided by revenue for the same fiscal year.
| Fiscal year ended | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| Dec 2025 | 40.0% | 13.4% | 10.1% |
| Dec 2024 | 41.7% | 13.3% | 10.1% |
| Dec 2023 | 40.5% | 12.5% | 8.0% |
| Dec 2022 | 39.1% | 13.8% | 10.4% |
| Dec 2021 | 40.8% | 15.9% | 12.8% |
Source: SEC EDGAR XBRL company facts for CIK 1932393 (raw data). Most recent filing in this dataset: 10-Q filed Oct 28, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.